Immunothrombosis: A Bibliometric Analysis from 2003 to 2023

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2024 Sep 17

PMID 39287275

Authors

Mengyu Hou

Jingxuan Wu

Jiangshuo Li

Meijuan Zhang

Hang Yin

Jingcheng Chen

Zhili Jin

Ruihua Dong

Affiliations

Soon will be listed here.

Abstract

Background: Immunothrombosis is a physiological process that constitutes an intravascular innate immune response. Abnormal immunothrombosis can lead to thrombotic disorders. With the outbreak of COVID-19, there is increasing attention to the mechanisms of immunothrombosis and its critical role in thrombotic events, and a growing number of relevant research papers are emerging. This article employs bibliometrics to discuss the current status, hotspots, and trends in research of this field.

Methods: Research papers relevant to immunothrombosis published from January 1, 2003, to May 29, 2023, were collected from the Web of Science Core Collection database. VOSviewer and the R package "Bibliometrix" were employed to analyze publication metrics, including the number of publications, authors, countries, institutions, journals, and keywords. The analysis generated visual results, and trends in research topics and hotspots were examined.

Results: A total of 495 target papers were identified, originating from 58 countries and involving 3287 authors from 1011 research institutions. Eighty high-frequency keywords were classified into 5 clusters. The current key research topics in the field of immunothrombosis include platelets, inflammation, neutrophil extracellular traps, Von Willebrand factor, and the complement system. Research hotspots focus on the mechanisms and manifestations of immunothrombosis in COVID-19, as well as the discovery of novel treatment strategies targeting immunothrombosis in cardiovascular and cerebrovascular diseases.

Conclusion: Bibliometric analysis summarizes the main achievements and development trends in research on immunothrombosis, offering readers a comprehensive understanding of the field and guiding future research directions.

References

Mastellos D, Pires da Silva B, Fonseca B, Fonseca N, Auxiliadora-Martins M, Mastaglio S . Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Clin Immunol. 2020; 220:108598. PMC: 7501834. DOI: 10.1016/j.clim.2020.108598. View

Borczuk A, Yantiss R . The pathogenesis of coronavirus-19 disease. J Biomed Sci. 2022; 29(1):87. PMC: 9597981. DOI: 10.1186/s12929-022-00872-5. View

Chen-Goodspeed A, Dronavalli G, Zhang X, Podbielski J, Patel B, Modis K . Antithrombin Activity Is Associated with Persistent Thromboinflammation and Mortality in Patients with Severe COVID-19 Illness. Acta Haematol. 2022; 146(2):117-124. PMC: 9940263. DOI: 10.1159/000528584. View

Cebo M, Dittrich K, Fu X, Manke M, Emschermann F, Rheinlaender J . Platelet ACKR3/CXCR7 favors antiplatelet lipids over an atherothrombotic lipidome and regulates thromboinflammation. Blood. 2021; 139(11):1722-1742. DOI: 10.1182/blood.2021013097. View

Bikdeli B, Madhavan M, Gupta A, Jimenez D, Burton J, Nigoghossian C . Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020; 120(7):1004-1024. PMC: 7516364. DOI: 10.1055/s-0040-1713152. View

Nicolai L, Leunig A, Brambs S, Kaiser R, Joppich M, Hoffknecht M . Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia. J Thromb Haemost. 2020; 19(2):574-581. PMC: 7753335. DOI: 10.1111/jth.15179. View

Stevens H, McFadyen J . Platelets as Central Actors in Thrombosis-Reprising an Old Role and Defining a New Character. Semin Thromb Hemost. 2019; 45(8):802-809. DOI: 10.1055/s-0039-1698829. View

Dib P, Quirino-Teixeira A, Merij L, Pinheiro M, Rozini S, Andrade F . Innate immune receptors in platelets and platelet-leukocyte interactions. J Leukoc Biol. 2020; 108(4):1157-1182. DOI: 10.1002/JLB.4MR0620-701R. View

Bonaventura A, Vecchie A, Dagna L, Martinod K, Dixon D, Van Tassell B . Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021; 21(5):319-329. PMC: 8023349. DOI: 10.1038/s41577-021-00536-9. View

10.

Hsu L, Chen P, Chang W, Lee W, Liu P . The Role of ROCK in Platelet-Monocyte Collaborative Induction of Thromboinflammation during Acute Coronary Syndrome. Thromb Haemost. 2020; 120(10):1417-1431. DOI: 10.1055/s-0040-1714278. View

11.

Sun H, Bai W, Li X, Huang H, Cui X, Cheung T . Schizophrenia and Inflammation Research: A Bibliometric Analysis. Front Immunol. 2022; 13:907851. PMC: 9219580. DOI: 10.3389/fimmu.2022.907851. View

12.

Middleton E, He X, Denorme F, Campbell R, Ng D, Salvatore S . Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020; 136(10):1169-1179. PMC: 7472714. DOI: 10.1182/blood.2020007008. View

13.

Storm B, Christiansen D, Fure H, Ludviksen J, Lau C, Lambris J . Air Bubbles Activate Complement and Trigger Hemostasis and C3-Dependent Cytokine Release Ex Vivo in Human Whole Blood. J Immunol. 2021; 207(11):2828-2840. PMC: 8611197. DOI: 10.4049/jimmunol.2100308. View

14.

Gaertner F, Massberg S . Blood coagulation in immunothrombosis-At the frontline of intravascular immunity. Semin Immunol. 2016; 28(6):561-569. DOI: 10.1016/j.smim.2016.10.010. View

15.

Jin R, Xiao A, Chen R, Granger D, Li G . Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation. Stroke. 2017; 48(12):3356-3365. PMC: 5726599. DOI: 10.1161/STROKEAHA.117.018839. View

16.

de la Morena-Barrio M, Bravo-Perez C, Minano A, de la Morena-Barrio B, Fernandez-Perez M, Bernal E . Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients. Sci Rep. 2021; 11(1):7792. PMC: 8032761. DOI: 10.1038/s41598-021-85906-y. View

17.

Schrottmaier W, Mussbacher M, Salzmann M, Assinger A . Platelet-leukocyte interplay during vascular disease. Atherosclerosis. 2020; 307:109-120. DOI: 10.1016/j.atherosclerosis.2020.04.018. View

18.

Frantzeskaki F, Armaganidis A, Orfanos S . Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation. Respiration. 2016; 93(3):212-225. DOI: 10.1159/000453002. View

19.

Szepanowski R, Haupeltshofer S, Vonhof S, Frank B, Kleinschnitz C, Casas A . Thromboinflammatory challenges in stroke pathophysiology. Semin Immunopathol. 2023; 45(3):389-410. PMC: 10241149. DOI: 10.1007/s00281-023-00994-4. View

20.

Griffin J, Lyden P . COVID-19 hypothesis: Activated protein C for therapy of virus-induced pathologic thromboinflammation. Res Pract Thromb Haemost. 2020; 4(4):506-509. PMC: 7292662. DOI: 10.1002/rth2.12362. View